Céline Dubath

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


18 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
2024
DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study.
Dubath C., Porcu E., Delacrétaz A., Grosu C., Laaboub N., Piras M., von Gunten A., Conus P., Plessen K.J., Kutalik Z. et al., 2024/02/28. Clinical epigenetics, 16 (1) p. 36. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_37368679B832]
2023
 
Prescription d’antipsychotiques chez les adultes : à quoi faut-il être attentif ? [Antipsychotic prescribing in adults : what to watch out for ?]
Grandjean C., Vandenberghe F., Dubath C., Sibailly G., Ansermot N., Crettol Wavre S., Eap C.B., 2023/09/20. Revue medicale suisse, 19 (842) pp. 1707-1712. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A5F7D63D1926]
2022
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.
Perry B.I., Vandenberghe F., Garrido-Torres N., Osimo E.F., Piras M., Vazquez-Bourgon J., Upthegrove R., Grosu C., De La Foz V.O., Jones P.B. et al., 2022/11. The Lancet regional health. Europe, 22 p. 100493. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A56B7AE8F057]
 
Effects of psychotropic switches on weight change: a prospective cohort study
Piras M., Ranjbar S., Dubath C., Laaboub N., Grosu C., Gamma F., Von Plessen K., Von Gunten A., Conus P., Eap C., 2022/06. pp. S731-S731 dans European Psychiatry.
[DOI][WoS][serval:BIB_DBCC0A772A3C]
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.
Laaboub N., Dubath C., Ranjbar S., Sibailly G., Grosu C., Piras M., Délessert D., Richard-Lepouriel H., Ansermot N., Crettol S. et al., 2022/05/17. BMC psychiatry, 22 (1) p. 342. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2E9824076089]
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort.
Schoretsanitis G., Dubath C., Grosu C., Piras M., Laaboub N., Ranjbar S., Ansermot N., Crettol S., Vandenberghe F., Gamma F. et al., 2022/04. Basic & clinical pharmacology & toxicology, 130 (4) pp. 531-541. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_995572119F81]
Body Composition Assessment by Dual-Energy X-Ray Absorptiometry: A Useful Tool for the Diagnosis of Lipedema.
Buso G., Favre L., Vionnet N., Gonzalez-Rodriguez E., Hans D., Puder J.J., Dubath C., Eap C.B., Raffoul W., Collet T.H. et al., 2022. Obesity facts, 15 (6) pp. 762-773. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0D55E2287696]
2021
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study.
Dubath C., Piras M., Gholam M., Laaboub N., Grosu C., Sentissi O., Gamma F., Solida A., von Gunten A., Conus P. et al., 2021/11. Pharmacopsychiatry, 54 (6) pp. 279-286. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_615A39552FB8]
Metabolomic alteration induced by psychotropic drugs: Short-term metabolite profile as a predictor of weight gain evolution.
Lenski M., Sidibé J., Gholam M., Hennart B., Dubath C., Augsburger M., von Gunten A., Conus P., Allorge D., Thomas A. et al., 2021/11. Clinical and translational science, 14 (6) pp. 2544-2555. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B399E4FCFB6A]
Valproate is associated with early decrease of high-density lipoprotein cholesterol levels in the psychiatric population.
Delacrétaz A., Glatard A., Dubath C., Gholam M., Gamma F., von Gunten A., Conus P., Eap C.B., 2021/07. Basic and clinical pharmacology and toxicology, 129 (1) pp. 26-35. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EBB73A5FE75D]
Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort.
Dubath C., Gholam-Rezaee M., Sjaarda J., Levier A., Saigi-Morgui N., Delacrétaz A., Glatard A., Panczak R., Correll C.U., Solida A. et al., 2021/06/26. Translational psychiatry, 11 (1) p. 360. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4391765D562C]
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort.
Laaboub N., Gholam M., Sibailly G., Sjaarda J., Delacrétaz A., Dubath C., Grosu C., Piras M., Ansermot N., Crettol S. et al., 2021. Frontiers in psychiatry, 12 p. 756403. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C84BB0F598EF]
2020
Evaluation of Cardiometabolic Risk in a Large Psychiatric Cohort and Comparison With a Population-Based Sample in Switzerland.
Dubath C., Delacrétaz A., Glatard A., Vollenweider P., Preisig M., Richard-Lepouriel H., Hasler R., Gamma F., Solida A., Thonney J. et al., 2020/03/31. The Journal of clinical psychiatry, 81 (3) pp. 19m12796. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5B06662CFA57]
Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses.
Glatard A., Guidi M., Delacrétaz A., Dubath C., Grosu C., Laaboub N., von Gunten A., Conus P., Csajka C., Eap C.B., 2020/03. Clinical pharmacokinetics, 59 (3) pp. 371-382. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_750BA5D2C6D5]
Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication.
Alameda L., Levier A., Gholam-Rezaee M., Golay P., Vandenberghe F., Delacretaz A., Baumann P., Glatard A., Dubath C., Herane-Vives A. et al., 2020. PloS one, 15 (12) pp. e0242569. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9615E0192FAB]
2019
Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patients.
Delacrétaz A., Glatard A., Dubath C., Gholam-Rezaee M., Sanchez-Mut J.V., Gräff J., von Gunten A., Conus P., Eap C.B., 2019/12/26. Clinical epigenetics, 11 (1) p. 198. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7876169F9529]
Lipid Disturbances in Adolescents Treated With Second-Generation Antipsychotics: Clinical Determinants of Plasma Lipid Worsening and New-Onset Hypercholesterolemia.
Delacrétaz A., Vandenberghe F., Glatard A., Dubath C., Levier A., Gholam-Rezaee M., Holzer L., Ambresin A.E., Conus P., Eap C.B., 2019/04/09. The Journal of clinical psychiatry, 80 (3). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B98038AE6722]
2018
Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances
Delacrétaz Aurélie, Vandenberghe Frederik, Glatard Anaïs, Levier Axel, Dubath Céline, Ansermot Nicolas, Crettol Séverine, Gholam-Rezaee Mehdi, Guessous Idris, Bochud Murielle et al., 2018/11/09. Frontiers in Psychiatry, 9.
[URN][DOI][WoS][Pmid][serval:BIB_EFD90D5BB70B]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University